RecruitingNot ApplicableNCT03827941

Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism


Sponsor

Massachusetts General Hospital

Enrollment

40 participants

Start Date

Nov 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 1 Hz Auricular transcutaneous electrical nerve stimulation and 20 Hz Auricular transcutaneous electrical nerve stimulation for people with autism spectrum disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER1 Hz Auricular transcutaneous electrical nerve stimulation

High-functioning individuals with autism randomized to this group will receive 1 Hz tVNS stimulation for 30 minutes/day up to 5 times/week for 3 weeks.

OTHER20 Hz Auricular transcutaneous electrical nerve stimulation

High-functioning individuals with autism randomized to this group will receive 1 Hz tVNS stimulation for 30 minutes/day up to 5 times/week for 3 weeks.


Locations(1)

MGB

Charlestown, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03827941


Related Trials